This NDC is on FDA's drug shortage list (posted Jul 14, 2023)
Reported reason: Shortage of an active ingredient
Product Information
LISDEXAMFETAMINE 10 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $2.6240 per EA under NDC 43547060210. Its NADAC has been published 150 times since Nov 22, 2023.
FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547060210
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA216266FDA Approved
8/25/2023
TE Code
AB
On Market Since
8/26/2023
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 10 MG CAPSULE has been published 150 times since Nov 22, 2023, and over the history we have for it it has declined 55.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6240 per EA |
|---|---|
| All-time high | $5.9486 (Mar 13, 2024) |
| All-time low | $2.6240 (Sep 23, 2026) |
| 52-week high | $3.5435 |
| 52-week low | $2.6240 |
| Median price | $4.0062 |
| Average price | $4.1047 |
| Largest weekly change | +34.4% (Jan 17, 2024) |
| Weeks tracked | 150 |
| Tracking since | Nov 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lisdexamfetamine dimesylate capsules market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lisdexamfetamine dimesylate capsules market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 10 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $2.6240 per EA (NDC 43547060210), effective Sep 30, 2026.
How has the price of LISDEXAMFETAMINE 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 10 MG CAPSULE has declined 55.4%. It has been tracked across 150 weekly CMS publications since Nov 22, 2023.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 10 MG CAPSULE?
Since Nov 22, 2023, the NADAC for LISDEXAMFETAMINE 10 MG CAPSULE has ranged from a low of $2.6240 (Sep 23, 2026) to a high of $5.9486 (Mar 13, 2024), with a median of $4.0062 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 10 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of LISDEXAMFETAMINE 10 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LISDEXAMFETAMINE 10 MG CAPSULE?
LISDEXAMFETAMINE 10 MG CAPSULE (NDC 43547060210) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Is LISDEXAMFETAMINE 10 MG CAPSULE in shortage?
Yes — NDC 43547060210 is currently listed in FDA's drug shortage database (posted Jul 14, 2023). Reported reason: Shortage of an active ingredient.